Block copolymer self-assembled and cross-linked nanoassemblies for combination delivery of iron oxide and doxorubicin

Journal of Applied Pharmaceutical Science

Volumn 3, Issue 6, 2013, Pages 21-28

  Scott, Daniel ^a   Beabout, Yihwa ^b   Wydra, Robert J ^c   Dan, Mo ^a   Yokel, Robert ^a   Zach Hilt, J ^c   Bae, Younsoo ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF SOUTHERN INDIANA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Block copolymers; Controlled release; Drug delivery; Iron oxide.; Nanoassemblies; Nanoparticle

Indexed keywords

EID: 84882624296     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2013.3604     Document Type: Article

References (52)

1. Bae Y., Jang W.-D., Nishiyama N., Fukushima S., and Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol BioSyst 2005; 3: 242-250.
2. Bae Y., and Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliver Rev 2009; 10: 768-784.
3. Bae Y., and Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv Drug Deliv Rev 2009; 10: 768-784.
4. Bulte J.W.M., and Kraitchman D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR in Biomedicine 2004; 7: 484-499.
5. Eckman A.M., Tsakalozou E., Kang N.Y., Ponta A., and Bae Y. Drug Release Patterns and Cytotoxicity of PEG-poly(aspartate) Block Copolymer Micelles in Cancer Cells. Pharm Res 2012;
6. Fang J., Nakamura H., and Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliver Rev 2011; 3: 136-151.
7. Frimpong R.A., Dou J., Pechan M., and Hilt J.Z. Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation. J Magn Magn Mater 2010; 3: 326-331.
8. Frimpong R.A., and Hilt J.Z. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Nanomedicine 2010; 9: 1401-1414.
9. Frimpong R.A., and Hilt J.Z. Poly(n-isopropylacrylamide)-based hydrogel coatings on magnetite nanoparticles via atom transfer radical polymerization. Nanotechnology 2008; 17:
10. Fulda S., and Debatin K.M. Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 2006; 3: 217-223.
11. Grissom C.B. Magnetic-Field Effects in Biology - a Survey of Possible Mechanisms with Emphasis on Radical-Pair Recombination. Chem Rev 1995; 1: 3-24.
12. Harris L.A., GoffJ.D., Carmichael A.Y., Riffle J.S., Harburn J.J., St Pierre T.G., and Saunders M. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 6: 1367-1377.
13. He Z.W., Satarkar N., Xie T., Cheng Y.T., and Hilt J.Z. Remote Controlled Multishape Polymer Nanocomposites with Selective Radiofrequency Actuations. Adv Mater 2011; 28: 3192-+.
14. Ishida O., Maruyama K., Sasaki K., and Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999; 1: 49-56.
15. Jain T.K., Richey J., Strand M., Leslie-Pelecky D.L., Flask C.A., and Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008; 29: 4012-4021.
16. Khemtong C., Kessinger C.W., and Gao J. Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun 2009; 24: 3497-3510.
17. Kim R., Tanabe K., Uchida Y., Emi M., Inoue H., and Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 2002; 5: 343-352.
18. Konwarh R., Saikia J.P., Karak N., and Konwar B.K. 'Poly(ethylene glycol)-magnetic nanoparticles-curcumin' trio: Directed morphogenesis and synergistic free-radical scavenging. Colloid Surface B 2010; 2: 578-586.
19. Kumagai M., Imai Y., Nakamura T., Yamasaki Y., Sekino M., Ueno S., Hanaoka K., Kikuchi K., Nagano T., Kaneko E., Shimokado K., and Kataoka K. Iron hydroxide nanoparticles coated with poly(ethylene.glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloid Surface B 2007; 1-2: 174-181.
20. Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., and Muller R.N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 6: 2064-2110.
21. Lednev V.V. Possible Mechanism for the Influence of Weak Magnetic-Fields on Biological-Systems. Bioelectromagnetics 1991; 2: 71-75.
22. Lee H.J., and Bae Y. Cross-Linked Nanoassemblies from Poly(ethylene glycol)-poly(aspartate) Block Copolymers as Stable Supramolecular Templates for Particulate Drug Delivery. Biomacromolecules 2011; 7: 2686-2696.
23. Lee H.J., Ponta A., and Bae Y. Polymer nanoassemblies for cancer treatment and imaging. Therapeutic Delivery 2010; 6: 803-817.
24. Lee S.J., Min K.H., Lee H.J., Koo A.N., Rim H.P., Jeon B.J., Jeong S.Y., Heo J.S., and Lee S.C. Ketal Cross-Linked Poly(ethylene glycol)-Poly(amino acid)s Copolymer Micelles for Efficient Intracellular Delivery of Doxorubicin. Biomacromolecules 2011; 4: 1224-1233.
25. Lin M.M., Kim do K., El Haj A.J., and Dobson J. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE T Nanobiosci 2008; 4: 298-305.
26. Los M., Burek C.J., Stroh C., Benedyk K., Hug H., and Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today 2003; 2: 67-77.
27. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 1-2: 271-284.
28. Mahmoudi M., Laurent S., Shokrgozar M.A., and Hosseinkhani M. Toxicity Evaluations of Superparamagnetic Iron Oxide Nanoparticles: Cell "Vision" versus Physicochemical Properties of Nanoparticles. ACS Nano 2011; 9: 7263-7276.
29. Mahmoudi M., Simchi A., Milani A.S., and Stroeve P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 2009; 2: 510-518.
30. Marcos-Campos I., Asin L., Torres T.E., Marquina C., Tres A., Ibarra M.R., and Goya G.F. Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells. Nanotechnology 2011; 20: 205101.
31. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 12 Pt 1: 6387-6392.
32. Meenach S.A., Anderson K.W., and Hilt J.Z. Synthesis and Characterization of Thermoresponsive Poly(ethylene glycol)-Based Hydrogels and Their Magnetic Nanocomposites. J Polym Sci Pol Chem 2010; 15: 3229-3235.
33. Meenach S.A., Hilt J.Z., and Anderson K.W. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater 2010; 3: 1039-1046.
34. Min K.H., Lee H.J., Kim K., Kwon I.C., Jeong S.Y., and Lee S.C. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials 2012; 23: 5788-5797.
35. Neuberger T., Schöpf B., Hofmann H., Hofmann M., and von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005; 1: 483-496.
36. Obena R.P., Lin P.C., Lu Y.W., Li I.C., del Mundo F., Arco S., Nuesca G.M., Lin C.C., and Chen Y.J. Iron oxide nanomatrix facilitating metal ionization in matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 2011; 24: 9337-9343.
37. Papaphilippou P., Loizou L., Popa N.C., Han A., Vekas L., Odysseos A., and Krasia-Christoforou T. Superparamagnetic Hybrid Micelles, Based on Iron Oxide Nanoparticles and Well-Defined Diblock Copolymers Possessing beta-Ketoester Functionalities. Biomacromolecules 2009; 9: 2662-2671.
38. Ponta A., Akter S., and Bae Y. Degradable cross-linked nanoassemblies as drug carriers for heat shock protein 90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin. Pharmaceuticals 2011; 1281-1292.
39. Prompruk K., Govender T., Zhang S., Xiong C.D., and Stolnik S. Synthesis of a novel PEG-block-poly(aspartic acid-stat-phenylalanine) copolymer shows potential for formation of a micellar drug carrier. Int J Pharm 2005; 1-2: 242-253.
40. Sanvicens N., and Marco M.P. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Trends Biotechnol 2008; 8: 425-433.
41. Satarkar N.S., Biswal D., and Hilt J.Z. Hydrogel nanocomposites: a review of applications as remote controlled biomaterials. Soft Matter 2010; 11: 2364-2371.
42. Satarkar N.S., Meenach S.A., Anderson K.W., and Hilt J.Z. Remote Actuation of Hydrogel Nanocomposites: Heating Analysis, Modeling, and Simulations. AIChE J 2011; 4: 852-860.
43. Schladt T.D., Schneider K., Schild H., and Tremel W. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton T 2011; 24: 6315-6343.
44. Scott D., Rohr J., and Bae Y. Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity. Int J Nanomed 2011; 2757-2767.
45. Shen M., Cai H., Wang X., Cao X., Li K., Wang S.H., Guo R., Zheng L., Zhang G., and Shi X. Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology 2012; 10: 105601.
46. Singh N., Jenkins G.J., Asadi R., and Doak S.H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 2010;
47. Soenen S.J., and De Cuyper M. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine 2010; 8: 1261-1275.
48. Sumer B., and Gao J.M. Theranostic nanomedicine for cancer. Nanomedicine 2008; 2: 137-140.
49. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliver Rev 2011; 3: 131-135.
50. Walleczek J. Electromagnetic-Field Effects on Cells of the Immune-System - the Role of Calcium Signaling. Faseb J 1992; 13: 3177-3185.
51. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., and Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 8: 487-497.
52. Xie J., Liu G., Eden H.S., Ai H., and Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 2011; 10: 883-892.